WallStSmart

Alignment Healthcare LLC (ALHC)vsCigna Corp (CI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cigna Corp generates 6428% more annual revenue ($277.89B vs $4.26B). CI leads profitability with a 2.3% profit margin vs 0.5%. CI trades at a lower P/E of 2.4x. CI earns a higher WallStSmart Score of 68/100 (B-).

ALHC

Hold

48

out of 100

Grade: D+

Growth: 8.0Profit: 4.5Value: 4.3Quality: 6.0
Piotroski: 4/9Altman Z: 2.95

CI

Strong Buy

68

out of 100

Grade: B-

Growth: 6.7Profit: 5.5Value: 9.3Quality: 5.5
Piotroski: 5/9Altman Z: 2.50
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALHCUndervalued (+5.8%)

Margin of Safety

+5.8%

Fair Value

$21.64

Current Price

$15.37

$6.27 discount

UndervaluedFair: $21.64Overvalued
CIUndervalued (+57.5%)

Margin of Safety

+57.5%

Fair Value

$680.85

Current Price

$289.48

$391.37 discount

UndervaluedFair: $680.85Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALHC1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
33.3%10/10

Revenue surging 33.3% year-over-year

CI5 strengths · Avg: 8.6/10
P/E RatioValuation
2.4x10/10

Attractively priced relative to earnings

Market CapQuality
$72.14B9/10

Large-cap with strong market position

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

EPS GrowthGrowth
29.1%8/10

Earnings expanding 29.1% YoY

Areas to Watch

ALHC4 concerns · Avg: 3.5/10
Price/BookValuation
15.4x4/10

Trading at 15.4x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.5%3/10

0.5% margin — thin

Operating MarginProfitability
1.3%3/10

Operating margin of 1.3%

CI2 concerns · Avg: 3.5/10
Revenue GrowthGrowth
4.6%4/10

4.6% revenue growth

Profit MarginProfitability
2.3%3/10

2.3% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : ALHC

The strongest argument for ALHC centers on Revenue Growth. Revenue growth of 33.3% demonstrates continued momentum.

Bull Case : CI

The strongest argument for CI centers on P/E Ratio, Market Cap, PEG Ratio. PEG of 0.82 suggests the stock is reasonably priced for its growth.

Bear Case : ALHC

The primary concerns for ALHC are Price/Book, EPS Growth, Profit Margin. A P/E of 197.5x leaves little room for execution misses. Debt-to-equity of 1.59 is elevated, increasing financial risk.

Bear Case : CI

The primary concerns for CI are Revenue Growth, Profit Margin. Thin 2.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

ALHC profiles as a hypergrowth stock while CI is a value play — different risk/reward profiles.

ALHC carries more volatility with a beta of 1.15 — expect wider price swings.

ALHC is growing revenue faster at 33.3% — sustainability is the question.

CI generates stronger free cash flow (864M), providing more financial flexibility.

Bottom Line

CI scores higher overall (68/100 vs 48/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alignment Healthcare LLC

HEALTHCARE · HEALTHCARE PLANS · USA

Alignment Healthcare, Inc. provides a consumer-centric platform that provides personalized healthcare to seniors in the United States. The company is headquartered in Orange, California.

Cigna Corp

HEALTHCARE · HEALTHCARE PLANS · USA

Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).

Visit Website →

Want to dig deeper into these stocks?